Comments on effect of food on early drug exposure from extended-release stimulants:: Results from the CONCERTA®, Adderall XR® food evaluation study

被引:2
|
作者
González, MA
Polli, JE
Morgan, JA
机构
[1] GloboMax Amer LLC, Weston, FL 33326 USA
[2] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[3] Univ Maryland, Med Ctr, Dept Pharm Practice & Sci, Baltimore, MD 21201 USA
关键词
D O I
10.1185/030079902125001218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:VII / X
页数:4
相关论文
共 50 条
  • [41] Hand Washing Observations in Fast-Food and Full-Service Restaurants: Results from the 2014 US Food and Drug Administration Retail Food Risk Factors Study
    Verrill, L.
    Boyer, M.
    Williams, L.
    Otto, J.
    Lando, A.
    Dawood, N.
    Liggans, G.
    JOURNAL OF FOOD PROTECTION, 2021, 84 (06) : 1016 - 1022
  • [42] Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate: Evaluation of Dose Proportionality, Food Effect, Multiple-Dose Modeling, and Comparative Bioavailability with Immediate-Release Methylphenidate in Healthy Adults
    Liu, Tao
    Gobburu, Jogarao V. S.
    Po, Michelle D.
    McLean, Angus
    DeSousa, Norberto J.
    Sallee, Floyd R.
    Incledon, Bev
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (03) : 181 - 191
  • [43] Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS MethylphenidateA Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder
    Josep Antoni Ramos-Quiroga
    Rosa Bosch
    Xavier Castells
    Sergi Valero
    Mariana Nogueira
    Nuria Gomez
    Silvia Yelmo
    Marc Ferrer
    Yolanda Martinez
    Miguel Casas
    CNS Drugs, 2008, 22 : 603 - 611
  • [44] Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate:: A chart review of Spanish adults with attention-deficit hyperactivity disorder
    Ramos-Quiroga, Josep Antoni
    Bosch, Rosa
    Castells, Xavier
    Valero, Sergi
    Nogueira, Mariana
    Gomez, Nuria
    Yelmo, Silvia
    Ferrer, Marc
    Martinez, Yolanda
    Casas, Miguel
    CNS DRUGS, 2008, 22 (07) : 603 - 611
  • [45] Results from a phase III study of once-daily extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder
    Bandelow, B.
    Bobes, J.
    Ahokas, A.
    Eggens, I.
    Liu, S.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 314 - 315
  • [46] Results from a phase III study of extended release quetiapine fumarate (quetiapine XR) as add-on to antidepressants in patients with major depressive disorder (MDD)
    Bauer, M.
    Pretorius, H. W.
    Earley, W.
    Lindgren, P.
    Brecher, M.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 315 - 316
  • [47] Household food insecurity and overweight status in young school children: Results from the Early Childhood Longitudinal Study
    Rose, D
    Bodor, JN
    PEDIATRICS, 2006, 117 (02) : 464 - 473
  • [48] Household food security is associated with early childhood language development: results from a longitudinal study in rural Bangladesh
    Saha, K. K.
    Tofail, F.
    Frongillo, E. A.
    Rasmussen, K. M.
    Arifeen, S. E.
    Persson, L. A.
    Huda, S. N.
    Hamadani, J. D.
    CHILD CARE HEALTH AND DEVELOPMENT, 2010, 36 (03) : 309 - 316
  • [49] Bioavailability of once-daily amantadine extended-release tablets in healthy adult volunteers: Results from a randomized, crossover, open-label study
    Kumar, Sudershan
    Srivastava, Abhishek
    Devkare, Prashant
    Bedi, Simrata
    Khuroo, Arshad
    Singh, Romi
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [50] Changes in quality of life in ADHD-patients treated with extended-release Methylphenidate (OROS®-MPH) -: results from an open-label naturalistic study
    Mitt, C.
    Arend, W.
    Schauble, B.
    Hargarter, L.
    Mattejat, F.
    EUROPEAN PSYCHIATRY, 2008, 23 : S394 - S394